Compare BioNTech SE - ADR (BNTX) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Omnicom Group Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Omnicom Group Inc. trades at $85.74 (market cap $23.58B). The key difference: BioNTech SE - ADR and Omnicom Group Inc. are close in size by market cap, and Omnicom Group Inc. pays a 3.72% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | OMC | |
|---|---|---|
Market Cap | $23.31B | $23.58B |
Sector | Health | Media |
52-Week High | $119.34 | $86.22 |
52-Week Low | $83.89 | $67.27 |
Enterprise Value | $6.60B | $31.66B |
Dividend Yield | — | 3.72% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
